Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma

Part of paid clinical trials in Miami, Florida.

Sponsor
International Extranodal Lymphoma Study Group (IELSG)
Study ID
NCT05700149
Status
Recruiting
Apply to this trial

Conditions

  • Nodal Marginal Zone Lymphoma

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Study Details

International retrospective observational cohort study aimed to describe a molecular classification for NMZL.

Key Dates

First listed
Jan 26, 2023
Start date
Apr 11, 2024
Status verified
Jun 2026
Primary completion
Dec 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
300 participants (estimated)

Primary Outcome Measure

Define and quantify molecular subsets. [ Time Frame: Two years: from the end of samples collection to the end of study analysis ]

Central Contacts

Locations (4)

FacilityCityStateZIPSite coordinators
University of MiamiMiamiFlorida33136
Jennifer Chapman, MD
Jennifer Chapman, MD (PRINCIPAL_INVESTIGATOR)
Mayo ClinicRochesterMinnesota55905
Rebecca King, MD
Rebecca King, MD (PRINCIPAL_INVESTIGATOR)
Weill Cornell MedicalNew YorkNew York10065
Giorgio Inghirami, MD
Giorgio Inghirami, MD (PRINCIPAL_INVESTIGATOR)
Ohio Health Riverside Methodist HospitalColumbusOhio43214
William Basem, MD
William Basem (PRINCIPAL_INVESTIGATOR)

Find similar trials in Miami, FL

By research site
University of Miami· Miami, FLMayo Clinic· Rochester, MNWeill Cornell Medical· New York, NYOhio Health Riverside Methodist Hospital· Columbus, OH

Related Studies